BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Report

ALLIANCE FOR A STRONGER FDA

via ESHAM STRATEGIES LLC

2nd Quarter (Apr 1 - June 30) · 2025Posted Jun 27, 2025Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: ALLIANCE FOR A STRONGER FDA
Description: FDA Congressional Appropriations
Location: District of Columbia · United States of America

Registrant

Firm: ESHAM STRATEGIES LLC
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Budget/Appropriations
Issues related to FDA Congressional Budget/Appropriations
Lobbyistsms ELIZABETH CARTIER ESHAM
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

ALLIANCE FOR A STRONGER FDA — Lobbying — Receipts Report